Clinical Trials
Study Finds Fenebrutinib Cuts Disability Progression In PPMS
Roche announced late-breaking Phase III data showing that fenebrutinib reduces disability progression in PPMS, marking the first investigational advance for primary progressive multiple sclerosis in more than a decade. Results from the FENtrepid study showed the Bruton’s tyrosine kinase...
Business & Industry
Innovent-Lilly Partnership Expands Global Drug Development
Innovent Biologics has announced a strategic Innovent-Lilly partnership with Eli Lilly and Company to advance the global development of new medicines in oncology and immunology. The agreement represents the seventh partnership between the two companies and introduces a new...
Business & Industry
GSK Targets Faster Drug Development, Selective Acquisitions
GSK’s new chief executive, Luke Miels, said the drugmaker will prioritise faster drug development as it enters its next phase of growth, with a tighter focus on programmes that can change standards of care and selective bolt-on acquisitions. Miels,...
Business & Industry
UK and Japan Strengthen Science and Technology Ties by £33bn
The UK and Japanese governments have announced a wide-ranging partnership that sees UK and Japan strengthen science and technology ties across pharmaceuticals, genomics, quantum computing and advanced manufacturing. The agreement was confirmed during a visit to Japan by the...
News
ACG Packaging Materials Joins WEF Global Lighthouse Network
ACG Packaging Materials has announced that its Shirwal manufacturing facility has been formally designated a global Lighthouse and admitted into the World Economic Forum’s (WEF) Global Lighthouse Network (GLN). With this recognition, ACG becomes the world’s first pharmaceutical packaging...
News
Janumet and Weight Loss: Evidence, Expectations, and Safe Use
For people with type 2 diabetes, medication choices often balance glucose control with side effects, weight impact, and practical access. Combination therapies such as sitagliptin/metformin (brand: Janumet) sit within that balance. They are used to improve glycemic control and...
Business & Industry
Halo Pharma Emerges as the North American Drug Product CDMO
Halo Pharma becomes dedicated North American drug product CDMO after emerging as a standalone contract development and manufacturing organization focused exclusively on drug product services in North America. The transition follows SK Capital Partners’ decision to divest the active...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read